Splenic rupture from metastatic granulosa cell tumor 29 years after curative resection: case report and review of the literature

David K W Chew; Richard W Schutzer; Gregory S Domer; Mohammed A Jaloudi; Ann M Rogers

Splenic rupture from metastatic granulosa cell tumor 29 years after curative resection: case report and review of the literature

Am Surg. 2003 Feb;69(2):106-8.

Authors

David K W Chew¹, Richard W Schutzer, Gregory S Domer, Mohammed A Jaloudi, Ann M Rogers

Affiliation

¹ Department of Surgery, St. Luke's-Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, New York 10019, USA.

PMID: 12641348

Abstract

Granulosa cell tumors account for 2 to 3 per cent of all ovarian neoplasms. This case report describes a patient with splenic rupture from a bulky metastatic deposit 29 years after her initial surgery. A review of the literature regarding the patterns and timing of recurrence is also discussed.

Publication types

Case Reports
Review

MeSH terms

Antimetabolites, Antineoplastic / administration & dosage
Antineoplastic Agents, Phytogenic / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Bleomycin / administration & dosage
Chemotherapy, Adjuvant
Cisplatin / administration & dosage
Etoposide / administration & dosage
Female
Granulosa Cell Tumor / blood
Granulosa Cell Tumor / secondary*
Granulosa Cell Tumor / therapy
Humans
Hysterectomy*
Middle Aged
Ovarian Neoplasms / pathology*
Ovarian Neoplasms / surgery
Ovariectomy*
Rupture, Spontaneous
Splenectomy
Splenic Neoplasms / blood
Splenic Neoplasms / secondary*
Splenic Neoplasms / therapy
Splenic Rupture / etiology*
Time Factors
Tomography, X-Ray Computed
Treatment Outcome

Substances

Antimetabolites, Antineoplastic
Antineoplastic Agents, Phytogenic
Bleomycin
Etoposide
Cisplatin